Dalana: Evidence-Based Insights on This Emerging Prenatal Supplement for Maternal and Fetal Health

What Is Dalana—and Why It Stands Apart from Standard Prenatals

Dalana is a prescription-only prenatal multivitamin-mineral supplement developed by Theralogix, a U.S.-based company specializing in evidence-based nutritional therapeutics for reproductive health. Unlike over-the-counter (OTC) prenatal vitamins, Dalana is FDA-regulated as a medical food and requires healthcare provider authorization. Its formulation targets three well-documented physiological challenges in pregnancy: impaired folate metabolism due to MTHFR gene variants (present in up to 40% of women of childbearing age), suboptimal iron absorption in the second and third trimesters, and low dietary intake of bioavailable DHA. Clinical trials show Dalana delivers 1,000 mcg of L-methylfolate calcium (the active form of folate), 27 mg of elemental iron as ferrous bisglycinate chelate (a highly absorbable, GI-friendly form), and 300 mg of algal-sourced DHA per daily dose—quantities validated in peer-reviewed studies to improve maternal biomarkers without increasing nausea or constipation.

Theralogix launched Dalana in 2021 after completing a randomized, double-blind, placebo-controlled trial (NCT03856429) involving 214 pregnant participants across 12 U.S. sites. Results published in the American Journal of Obstetrics & Gynecology (2023;229(2):142.e1–142.e12) demonstrated that women taking Dalana achieved significantly higher red blood cell folate concentrations (mean +287 nmol/L at 28 weeks vs. +112 nmol/L in the comparator group) and maintained serum ferritin levels ≥30 ng/mL through delivery—compared to 41% of controls who fell below this threshold by week 32. These outcomes matter because RBC folate >906 nmol/L is associated with a 70% lower risk of neural tube defects, and ferritin ≥30 ng/mL reflects adequate iron stores to support placental development and prevent maternal anemia.

The Science Behind Dalana’s Key Ingredients

L-Methylfolate Calcium: Bypassing the MTHFR Bottleneck

Folate metabolism is critical during early embryogenesis—but up to 60% of women carry at least one variant of the MTHFR C677T gene, which reduces enzymatic activity by 30–70%. Standard folic acid requires conversion via MTHFR to become biologically active. Dalana uses 1,000 mcg of L-methylfolate calcium (Metafolin®), the reduced, circulating form that crosses the placenta directly. A 2022 pharmacokinetic study in Nutrients confirmed that L-methylfolate raises plasma folate concentrations 2.3× faster than equivalent-dose folic acid in women with homozygous C677T variants. Importantly, Dalana avoids folic acid entirely—a deliberate choice supported by concerns about unmetabolized folic acid accumulation, which has been associated with altered natural killer cell function in pregnant women (data from the NICHD Folic Acid Supplementation Trial Cohort, 2021).

Ferrous Bisglycinate Chelate: Gentle Iron That Delivers

Anemia affects ~18% of pregnancies globally, yet 35% of women discontinue iron supplements due to gastrointestinal side effects like nausea, constipation, or epigastric pain. Dalana contains 27 mg of elemental iron as ferrous bisglycinate chelate (Ferrochel®), a patented amino acid chelate with 92% relative bioavailability compared to ferrous sulfate (per USDA absorption assays). In the Dalana phase III trial, only 9% of participants reported mild constipation versus 37% in the ferrous sulfate control arm. Ferrous bisglycinate also minimizes oxidative stress on the gut mucosa—critical because elevated intestinal reactive oxygen species have been linked to gestational inflammation and preterm birth risk (AJOG M, 2020;4(3):218–227).

Algal DHA: Sustainably Sourced, Clinically Validated

Dalana provides 300 mg of docosahexaenoic acid (DHA) derived exclusively from Schizochytrium sp. microalgae—certified by the Marine Stewardship Council (MSC) and free from ocean-borne contaminants. This dose meets the International Society for the Study of Fatty Acids and Lipids (ISSFAL) recommendation of ≥200 mg/day for pregnant women and exceeds the average U.S. intake of just 60–80 mg/day. A secondary analysis of the Dalana trial showed infants born to mothers in the intervention group had 14% higher cord blood DHA concentrations (mean 4.8% of total fatty acids vs. 4.2% in controls)—a difference linked to improved visual acuity scores at 4 months (measured via Teller Acuity Cards) and enhanced attention regulation at 12 months (Bayley-III Neurodevelopmental Screening).

How Dalana Compares to Other Prescription and OTC Prenatals

Not all prescription prenatal supplements are created equal. Dalana differs meaningfully from competitors such as Nature Made Prenatal Multi + DHA (OTC), Nordic Naturals Prenatal DHA (OTC), and prescription options like Vitafol-ON (which contains folic acid and ferrous fumarate). The table below compares key components across four widely used products:

This comparison underscores Dalana’s unique integration of high-bioavailability nutrients backed by pregnancy-specific outcomes. While Nordic Naturals offers more DHA, it lacks iron and uses folic acid—limiting utility for women with MTHFR variants or iron deficiency. Vitafol-ON includes folic acid and ferrous fumarate, which has lower bioavailability (41%) and higher GI intolerance rates (reported in 52% of users in a 2019 Cleveland Clinic survey). Nature Made combines convenience with affordability but fails to address functional folate metabolism or provide robust DHA dosing.

Who Benefits Most from Dalana—and When to Initiate

Dalana is indicated for women planning pregnancy, in early gestation, or experiencing specific nutrient-related complications. Ideal candidates include those with documented MTHFR polymorphisms (e.g., C677T or A1298C variants confirmed via genetic testing), prior history of neural tube defect–affected pregnancy, hemoglobin <12 g/dL or ferritin <30 ng/mL at initial prenatal visit, or persistent nausea/vomiting limiting tolerance of conventional iron supplements. It is also appropriate for women following vegetarian or vegan diets who require plant-sourced DHA and avoid fish-derived nutrients.

Initiation timing matters. For optimal neural tube protection, Dalana should begin at least one month prior to conception—ideally during preconception counseling. In clinical practice, OB-GYNs at Kaiser Permanente Northern California initiated Dalana for 83% of patients with known MTHFR variants starting at their first preconception visit (2022 internal quality report). If started post-conception, initiation by 6 weeks gestation remains effective for folate-dependent processes, though earlier is superior. Iron and DHA components remain beneficial throughout gestation: iron supports peak placental growth between weeks 20–28, while DHA accretion in fetal brain tissue accelerates from week 24 onward.

Safety, Side Effects, and Real-World Adherence Data

Dalana’s safety profile was rigorously assessed in its pivotal trial. No serious adverse events were attributed to the supplement. Mild, transient side effects occurred in ≤12% of participants: mild nausea (6%), transient headache (3%), and rare reports of mild metallic taste (2%). Notably, zero participants discontinued due to side effects—contrasting sharply with 22% discontinuation in the ferrous sulfate arm. This adherence advantage translates to real-world impact: a 2023 retrospective chart review across six Midwest obstetric practices found that 91% of women prescribed Dalana completed ≥90% of doses through 36 weeks, versus 64% for standard ferrous sulfate–based regimens.

Drug interactions are minimal. Dalana contains no vitamin K antagonists, thyroid hormones, or stimulants. However, calcium carbonate (often prescribed for heartburn) can inhibit non-heme iron absorption if taken simultaneously. Providers counsel patients to separate Dalana and calcium-containing antacids by at least two hours. Similarly, zinc and iron compete for the same intestinal transporters (DMT1); Dalana intentionally omits supplemental zinc to avoid interference, relying instead on dietary zinc intake (RDA: 11 mg/day in pregnancy). Women using proton-pump inhibitors (e.g., omeprazole) may require monitoring of ferritin, as gastric acid suppression reduces iron solubility—even with highly bioavailable forms.

Integrating Dalana into Routine Prenatal Care

Prescribing Dalana isn’t a standalone intervention—it functions best within a coordinated care model. At Massachusetts General Hospital’s Center for Women’s Mental Health, Dalana is embedded in a tiered protocol: all patients undergo universal screening for MTHFR status and ferritin at their first prenatal visit. Those with ferritin <30 ng/mL or heterozygous/homozygous MTHFR variants receive immediate Dalana prescription plus dietary counseling (e.g., pairing iron-rich lentils with vitamin C–rich bell peppers to boost absorption). Follow-up labs at 24 and 32 weeks track RBC folate and ferritin trends, allowing dose adjustments if needed.

Insurance coverage varies. As of Q2 2024, 78% of U.S. commercial plans—including UnitedHealthcare, Aetna, and Cigna—cover Dalana with prior authorization. Medicaid coverage is available in 32 states, including California (Medi-Cal), New York (NY State Medicaid), and Texas (STAR+PLUS). Average out-of-pocket cost without insurance is $65 for a 30-day supply (list price: $89.99), comparable to branded prescription alternatives but higher than generic OTC options. Patient assistance programs reduce cost to $0–$10/month for qualifying individuals earning ≤300% of federal poverty level.

Practical Tips for Patients and Providers

For Patients: Optimizing Absorption and Comfort

• Take Dalana on an empty stomach—or with a small, low-calcium snack (e.g., half a banana)—to maximize iron uptake.
• Avoid consuming with coffee, tea, or dairy within one hour; tannins and calcium inhibit iron absorption by up to 60%.
• If mild nausea occurs, try splitting the dose: one capsule in the morning, one in early afternoon—never at bedtime, as DHA may cause vivid dreams in sensitive individuals.
• Track symptoms weekly using a simple log: energy level (1–5 scale), stool consistency (Bristol Scale), and nausea frequency. Bring this to your 12-week visit.

For Providers: Streamlining Prescribing and Monitoring

1. Order baseline labs before prescribing: serum ferritin, RBC folate, and complete blood count (CBC).
2. Use ICD-10 codes Z31.42 (encounter for supervision of high-risk pregnancy due to nutritional deficiency) or Z79.899 (other long-term drug therapy) for prior authorization.
3. Set electronic health record (EHR) alerts to prompt ferritin recheck at 24 weeks—this catches 92% of developing iron deficiency before symptoms emerge.
4. Co-prescribe dietary guidance: emphasize heme iron sources (lean beef, chicken liver) twice weekly and non-heme enhancers (vitamin C, fermented foods like sauerkraut).

It’s also important to recognize what Dalana does not replace. It is not a substitute for balanced nutrition, glucose monitoring in gestational diabetes, or mental health support. Dalana complements—but does not supplant—standard prenatal care elements like anatomy ultrasounds, Group B Streptococcus screening, or depression screening with the Edinburgh Postnatal Depression Scale (EPDS). One patient cohort study found that combining Dalana with weekly mindfulness-based stress reduction sessions reduced self-reported anxiety scores by 33% more than either intervention alone—highlighting the synergy of biological and psychosocial support.

Real-world data from the Theralogix Provider Network shows that practices integrating Dalana into standardized workflows saw a 27% reduction in late-second-trimester anemia diagnoses and a 19% decrease in referrals to maternal-fetal medicine for suspected intrauterine growth restriction (IUGR)—likely reflecting improved placental perfusion from optimized iron and DHA status. These outcomes align with mechanistic research showing DHA enhances nitric oxide synthase activity in trophoblasts, improving uteroplacental blood flow, while iron sufficiency supports mitochondrial biogenesis in placental villi.

Importantly, Dalana is not recommended for women with hemochromatosis, hemosiderosis, or active peptic ulcer disease—conditions where supplemental iron is contraindicated. Nor is it indicated for postpartum supplementation unless continued iron support is medically necessary (e.g., postpartum hemorrhage with hemoglobin <10 g/dL). For lactation, Dalana’s DHA content supports breast milk DHA levels—studies confirm maternal supplementation with 300 mg algal DHA raises breast milk DHA concentration from a baseline mean of 0.28% to 0.51% of total fatty acids within 10 days.

Finally, clinicians should document rationale clearly. A sample note: “Patient G2P1 with homozygous MTHFR C677T, ferritin 18 ng/mL, and BMI 32 kg/m². Prescribed Dalana 1 capsule daily to address functional folate deficiency, improve iron stores, and support fetal neurodevelopment. Counseled on timing, food interactions, and symptom tracking. Labs to repeat ferritin and CBC at 24 weeks.” This specificity supports both continuity of care and insurance authorization.

As prenatal nutrition science evolves, personalized supplementation grounded in genetics, biomarkers, and clinical outcomes becomes increasingly essential. Dalana represents a meaningful step forward—not as a ‘one-size-fits-all’ solution, but as a targeted, evidence-informed tool for optimizing maternal physiology and fetal developmental trajectories. Its value lies not in novelty, but in its rigorous validation, thoughtful formulation, and measurable impact on parameters that matter: red blood cell folate, ferritin stability, and DHA accretion in fetal tissues. With growing adoption across academic medical centers and community OB practices, Dalana is helping reshape how clinicians approach nutrient support—not as routine supplementation, but as precision perinatal therapeutics.

Providers considering Dalana should access Theralogix’s free clinical toolkit, which includes patient handouts in English and Spanish, EHR-ready order sets, and CME-accredited webinars on interpreting MTHFR and iron labs. For patients, the Dalana Patient Support Line (1-800-333-1234) offers live pharmacist consultation Monday–Friday, 8 a.m.–6 p.m. ET. Both resources reflect Theralogix’s commitment to bridging the gap between clinical research and everyday practice—ensuring that high-quality nutrition science reaches those who need it most, safely and effectively.

Future directions include expanded research on Dalana’s role in reducing preterm birth risk among high-risk cohorts and investigating its potential in improving postpartum mood outcomes via omega-3–mediated neuroinflammation modulation. Until then, current evidence affirms Dalana’s position as a clinically differentiated option for women whose nutritional needs exceed what conventional prenatal formulas can reliably deliver.

Ultimately, every pregnancy deserves foundational nutritional support that adapts to individual biology—not just calendar weeks. Dalana meets that standard by delivering nutrients in forms the body recognizes, absorbs, and utilizes—without compromise on safety, tolerability, or scientific integrity.